Benitec Biopharma Inc. (BNTC)
NASDAQ: BNTC · Real-Time Price · USD
12.88
-0.14 (-1.08%)
At close: Aug 26, 2026, 4:00 PM EDT
12.85
-0.03 (-0.23%)
After-hours: Aug 26, 2026, 7:30 PM EDT
Benitec Biopharma Employees
Benitec Biopharma had 19 employees as of June 30, 2025. The number of employees increased by 3 or 18.75% compared to the previous year.
Employees
19
Change (1Y)
3
Growth (1Y)
18.75%
Revenue / Employee
n/a
Profits / Employee
-$2,186,421
Market Cap
442.48M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Jun 30, 2025 | 19 | 3 | 18.75% |
| Jun 30, 2024 | 16 | -2 | -11.11% |
| Jun 30, 2023 | 18 | 0 | - |
| Jun 30, 2022 | 18 | 4 | 28.57% |
| Jun 30, 2021 | 14 | 0 | - |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| EyePoint | 214 |
| Puma Biotechnology | 179 |
| Ocugen | 116 |
| Arcturus Therapeutics Holdings | 111 |
| Larimar Therapeutics | 71 |
| Lexeo Therapeutics | 63 |
| Atea Pharmaceuticals | 55 |
| Compass Therapeutics | 39 |
BNTC News
- 4 weeks ago - Wedbush bullish on Benitec Biopharma, initiates with an Outperform - TheFly
- 4 weeks ago - Benitec Biopharma initiated with an Outperform at Wedbush - TheFly
- 2 months ago - Guggenheim downgrades Benitec to Neutral, terminates coverage - TheFly
- 2 months ago - Benitec Biopharma downgraded to Neutral from Buy at Guggenheim - TheFly
- 3 months ago - Benitec Biopharma Releases Third Quarter 2026 Financial Results and Provides Operational Update - GlobeNewsWire
- 3 months ago - Benitec Biopharma Earnings release: Q3 2026 - Filings
- 3 months ago - Benitec Biopharma Quarterly report: Q3 2026 - Filings
- 3 months ago - Benitec Biopharma initiated with an Outperform at Evercore ISI - TheFly